FDA Inspection 1283792 — RCHP Billings-Missoula, LLC.
The FDA completed an inspection of RCHP Billings-Missoula, LLC. on August 5, 2025 in Missoula, MT. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 5, 2025
- Fiscal Year
- 2025
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Missoula, MT (United States)